Loading clinical trials...
Loading clinical trials...
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies (VANISH)
Conditions
Locations
21
United States
Center for Fetal Medicine & Women's Ultrasound
Los Angeles, California, United States
Stanford
Palo Alto, California, United States
University of Colorado
Aurora, Colorado, United States
Yale
New Haven, Connecticut, United States
Christiana Care
Newark, Delaware, United States
Emerald Coast ObGyn
Panama City, Florida, United States
Start Date
July 22, 2021
Primary Completion Date
November 29, 2023
Completion Date
November 29, 2023
Last Updated
September 25, 2024
NCT07234695
NCT07413224
NCT07195253
NCT05981521
NCT02872948
NCT02201862
Lead Sponsor
Natera, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions